---
title: "Hims & Hers Health (HIMS) Gets a Buy from Barclays"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285902429.md"
description: "Barclays analyst Glen Santangelo has maintained a Buy rating on Hims & Hers Health (HIMS) with a price target of $29.00. Santangelo, a 4-star analyst, has an average return of 3.5% and a 49.50% success rate. Hims & Hers Health also received a Buy rating from J.P. Morgan's Cory Carpenter, while Deutsche Bank assigned a Hold rating on May 5."
datetime: "2026-05-11T08:00:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285902429.md)
  - [en](https://longbridge.com/en/news/285902429.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285902429.md)
---

# Hims & Hers Health (HIMS) Gets a Buy from Barclays

Barclays analyst Glen Santangelo maintained a Buy rating on Hims & Hers Health today and set a price target of $29.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Santangelo is a 4-star analyst with an average return of 3.5% and a 49.50% success rate. Santangelo covers the Healthcare sector, focusing on stocks such as Cencora, Henry Schein, and Medline.

In addition to Barclays, Hims & Hers Health also received a Buy from J.P. Morgan’s Cory Carpenter in a report issued on April 24. However, on May 5, Deutsche Bank assigned a Hold rating to Hims & Hers Health (NYSE: HIMS).

### Related Stocks

- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [HIMY.US](https://longbridge.com/en/quote/HIMY.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [COR.US](https://longbridge.com/en/quote/COR.US.md)
- [HSIC.US](https://longbridge.com/en/quote/HSIC.US.md)
- [MDLN.US](https://longbridge.com/en/quote/MDLN.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)

## Related News & Research

- [Is Hims and Hers Health stock a buy after its latest dip?](https://longbridge.com/en/news/286450228.md)
- [Why Hims & Hers Health stock just crashed](https://longbridge.com/en/news/286133577.md)
- [$1000 Invested In Hims & Hers Health 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/286630207.md)
- [Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 7,950 Shares of Stock](https://longbridge.com/en/news/286984937.md)
- [Hims & Hers Massive Stock Drop Explained](https://longbridge.com/en/news/286954469.md)